A new collaborative program started in 2016 to scale up the model at provincial level and test innovations in information and communication technologies, such as updating the national TB information system and establishing an e-learning and certification system for TB-related healthcare providers.
The Grand Challenges China program, launched with the National Natural Science Foundation of China, has funded four projects focusing on innovative TB drug and vaccine research, as well as a structure-based HIV vaccine design.
Developing countries carry 90 percent of the world's communicable diseases burden. Gates said China's R&D investment and innovations could bring affordable drugs and health products to other developing countries and the disease surveillance system could be applied to other countries.
A report published in Globalization and Health in 2017 said China committed 3 billion U.S. dollars to 255 health, population, and water and sanitation projects in Africa between 2000 and 2017. It also built hospitals and malaria control centers, invested in medical equipment, provided anti-malarial treatment, and trained health care workers.
"China is listening to what these countries' priorities are. One of the foundation's missions in China is to motivate more Chinese innovators to contribute to the solution of severe public health challenges around the world," said Gates. "We're hopeful that China will engage in malaria elimination in a number of countries like in Southeast Asia and parts of Africa."
【国内英语资讯:Chinas growing innovation capacity to play bigger role in global health: Bill Gates】相关文章:
★ 强盗新郎
★ 卡尼面临的挑战
★ 美国外交的困局
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15